Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Imaging agents for monitoring changes of dopamine receptors and methods of using thereof

Patent ·
OSTI ID:1360974

The present invention is related generally to a method for screening subjects to determine those subjects more likely to develop diabetes by quantization of insulin producing cells. The present invention is also related to the diagnosis of diabetes and related to monitor disease progression or treatment efficacy of candidate drugs.

Research Organization:
The Regents of the University of California, Oakland, CA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
FG02-03ER63598
Assignee:
The Regents of the University of California
Patent Number(s):
9,662,059
Application Number:
12/110,135
OSTI ID:
1360974
Country of Publication:
United States
Language:
English

References (13)

Current Progress in Non-Invasive Imaging of Beta Cell Mass of the Endocrine Pancreas journal October 2006
11C-Fallypride: radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain journal January 2004
18F-Fallypride PET of Pancreatic Islets: In Vitro and In Vivo Rodent Studies journal June 2011
Longitudinal noninvasive PET-based   cell mass estimates in a spontaneous diabetes rat model journal June 2006
Preliminary assessment of extrastriatal dopamine d-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride journal July 1999
Systematic screening of potential β-cell imaging agents journal February 2004
Fluorine-18-l-Dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography as a Tool to Localize an Insulinoma or β-Cell Hyperplasia in Adult Patients journal April 2007
Imaging inflammation of the pancreatic islets in type 1 diabetes journal August 2004
Dopamine D2-like Receptors Are Expressed in Pancreatic Beta Cells and Mediate Inhibition of Insulin Secretion journal August 2005
Dopaminergic regulation of glucose-induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro journal March 2006
Diagnosis and Localization of Focal Congenital Hyperinsulinism by 18F-Fluorodopa PET Scan journal February 2007
Fluorinated benzamide neuroleptics—III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer journal April 1995
Brain imaging of 18F-fallypride in normal volunteers: Blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors journal September 2002

Similar Records

Self-assembling membranes and related methods thereof
Patent · Tue Aug 20 00:00:00 EDT 2013 · OSTI ID:1092756

Method for detecting the presence of prostate cancer
Patent · Tue Apr 13 00:00:00 EDT 2010 · OSTI ID:1176232

Method for identifying type I diabetes mellitus in humans
Patent · Tue Apr 12 00:00:00 EDT 2011 · OSTI ID:1016737

Related Subjects